II. Adverse Effects: Least Tolerated Agents (early discontinuation)

III. Adverse Effects: Anticholinergic Symptoms

  1. Most: Tricyclic Antidepressants (Tertiary amines)
  2. Least: SSRI, Bupropion, SARI, MAO inhibitors

IV. Adverse Effects: Weight gain (Histamine H1 receptor blockade)

V. Adverse Effects: Orthostatic Hypotension (alpha 1 receptor blockade)

  1. Most: Tricyclic Antidepressants (Tertiary amines)
  2. Least: Bupropion, SSRI

VI. Adverse Effects: Bleeding Risk (Drug Interaction)

  1. SSRI and SNRI agents increase risk of bleeding events when combined with Anticoagulants and antiplatelet agents
    1. Drug interactions occur primarily with Warfarin
    2. One additional patient on Warfarin for Atrial Fibrillation with SNRI or SSRI will have have a major bleeding event
      1. However, also affect other Anticoagulants such as Pradaxa and antiplatelet agents
  2. Most: Fluoxetine, Flovoxamine (especially with Warfarin)
  3. Least: Mirtazapine, Bupropion
  4. References
    1. (2014) Presc Lett 21(11): 65
    2. Sansone (2009) Psychiatry 6(7): 24–29 [PubMed]

VII. Adverse Effects: Cardiac arrhythmia (Type 1A Antiarrhythmic effect)

  1. Most: Tricyclic Antidepressants (Tertiary amines)
  2. Least: Bupropion, SSRI
    1. Although QT Prolongation has been seen with Citalopram and Escitalopram

VIII. Adverse Effects: Gastrointestinal effects (Serotonin reuptake blockade)

IX. Adverse Effects: Sedation (Histamine H1 receptor blockade)

X. Adverse Effects: Agitation or Insomnia

XI. Adverse Effects: Increased Seizure risk (Lower Seizure threshold)

XII. Adverse Effects: Sexual Dysfunction (Serotonin reuptake blockade)

XIII. Adverse Effects: Miscellaneous

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window